Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'drug safety' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 69 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Morganroth, J
      Focus on issues in measuring and interpreting changes in the QTc interval duration

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    2. Yamamoto, K; Tamura, T; Imai, R; Yamamoto, M
      Acute canine model for drug-induced torsades de pointes in drug safety evaluation - Influences of anesthesia and validation with quinidine and astemizole

      TOXICOLOGICAL SCIENCES
    3. Boothby, LA; Doering, PL
      FDA labeling system for drugs in pregnancy

      ANNALS OF PHARMACOTHERAPY
    4. Bortnichak, EA; Wise, RP; Salive, ME; Tilson, HH
      Proactive safety surveillance

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    5. Wang, JX; Donnan, PT; Steinke, D; MacDonald, TM
      The multiple propensity score for analysis of dose-response relationships in drug safety studies

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    6. Lewis, MA; Kuhl-Habich, D; von Rosen, J
      Drug use and adverse event monitoring in German children

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    7. van der Linden, PD; Nab, HW; Simonian, S; Stricker, BHC; Leufkens, HGM; Herings, RMC
      Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands

      PHARMACY WORLD & SCIENCE
    8. Kloner, RA; Brown, M; Prisant, LM; Collins, M
      Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy

      AMERICAN JOURNAL OF HYPERTENSION
    9. Park, BK; Kitteringham, NR; O'Neill, PM
      Metabolism of fluorine-containing drugs

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    10. Jackson, PR; Wallis, EJ; Haq, IU; Ramsay, LE
      Statins for primary prevention: at what coronary risk is safety assured?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    11. Ozdemir, V; Basile, VS; Masellis, M; Kennedy, JL
      Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    12. Stichtenoth, DO; Deicher, HRG; Frolich, JC
      Blood donors on medication

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    13. Gandhi, TK; Seger, DL; Bates, DW
      Identifying drug safety issues: from research to practice

      INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
    14. Dunson, DB; Haseman, JK; van Birgelen, APJM; Stasiewicz, S; Tennant, RW
      Statistical analysis of skin tumor data from Tg.AC mouse bioassays

      TOXICOLOGICAL SCIENCES
    15. Wang, PS; Lai, ZM; Tang, JL; Xu, WL; Mi, XW; Ma, FG
      Safety of hormonal steroid contraceptive use for hepatitis B virus carrierwomen

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    16. Beard, K
      We are all in this together (ISPE Presidential Address, 15th Annual Conference on Pharmacoepidemiology, Boston, 27 August 1999)

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    17. Leufkens, HG
      Pharmacoepidemiology and gastroenterology: a close couple

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    18. Ernst, E
      Herb-drug interactions: potentially important but woefully under-researched

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    19. Horton, J; Witt, C; Ottesen, EA; Lazdins, JK; Addiss, DG; Awadzi, K; Beach, MJ; Belizario, VY; Dunyo, SK; Espinel, M; Gyapong, JO; Hossain, M; Ismail, MM; Jayakody, RL; Lammie, PJ; Makunde, W; Richard-Lenoble, D; Selve, B; Shenoy, RK; Simonsen, PE; Wamae, CN; Weerasooriya, MV
      An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis

      PARASITOLOGY
    20. Mouzak, A; Agathos, P; Kerezoudi, E; Mantas, A; Vourdeli-Yiannakoura, E
      Transient ischemic attack in heavy cannabis smokers - How 'safe' is it?

      EUROPEAN NEUROLOGY
    21. Shemer, J
      The need for a post-marketing surveillance program in Israel

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    22. Shani, S
      Post-marketing surveillance and adverse drug reactions

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    23. Waller, PC; Lee, EH
      Responding to drug safety issues

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    24. Sakai, H; Hayashi, K; Origasa, H; Kusunoki, T
      An application of meta-analysis techniques in the evaluation of adverse experiences with antihypertensive agents

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    25. Amery, WK
      Why there is a need for pharmacovigilance

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    26. Bell, RA; Kravitz, RL; Wilkes, MS
      Direct-to-consumer prescription drug advertising and the public

      JOURNAL OF GENERAL INTERNAL MEDICINE
    27. Pieber, TR
      Long acting insulin analogues: Can they provide a basal insulin level?

      JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
    28. MANNINO S; TRONCON MG; WALLANDER MA; CATTARUZZI C; ROMANO F; AGOSTINIS L; MARIGHI PE; WALKER A
      OCULAR DISORDERS IN USERS OF H2 ANTAGONISTS AND OF OMEPRAZOLE

      Pharmacoepidemiology and drug safety
    29. HOPF G; KIMBEL KH
      SAFE PRESCRIBING (SICHERER VERORDNEN) - INFORMATION ON DRUG SAFETY FOR GERMAN PHYSICIANS

      Pharmacoepidemiology and drug safety
    30. COLLET JP; SCHAUBEL D; HANLEY J; SHARPE C; BOIVIN JF
      CONTROLLING CONFOUNDING WHEN STUDYING LARGE PHARMACOEPIDEMIOLOGIC DATABASES - A CASE-STUDY OF THE 2-STAGE SAMPLING DESIGN

      Epidemiology
    31. Possnecker, A; Cussler, K
      Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products

      ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN
    32. KARACHALIOS GN; HOUPAS P; TZIVISKOU E; PAPALIMNEOU V; GEORGIOU A; KARACHALIOU I; HALKIADAKI D
      PROSPECTIVE RANDOMIZED STUDY OF ONCE-DAILY VERSUS TWICE-DAILY AMIKACIN REGIMENS IN PATIENTS WITH SYSTEMIC INFECTIONS

      International journal of clinical pharmacology and therapeutics
    33. KAPLAN RC; PSATY BM; KRIESEL D; HECKBERT SR; SMITH NL; GILLETT C; GOLSTON AG
      REPLACING SHORT-ACTING NIFEDIPINE WITH ALTERNATIVE MEDICATIONS AT A LARGE HEALTH MAINTENANCE ORGANIZATION

      American journal of hypertension
    34. SCHAFER U
      PAST AND PRESENT CONCEPTIONS CONCERNING THE USE OF LITHIUM IN MEDICINE

      Journal of trace and microprobe techniques
    35. WIKELL C; BERGQVIST PBF; HJORTH S; APELQVIST G; BJORK H; BENGTSSON F
      BRAIN MONOAMINE OUTPUT ALTERATIONS AFTER A SINGLE VENLAFAXINE CHALLENGE IN EXPERIMENTAL HEPATIC-ENCEPHALOPATHY

      Clinical neuropharmacology
    36. MANN RD
      PRESCRIPTION-EVENT MONITORING - RECENT PROGRESS AND FUTURE HORIZONS

      British journal of clinical pharmacology
    37. TALBOT JCC; NILSSON BS
      PHARMACOVIGILANCE IN THE PHARMACEUTICAL-INDUSTRY

      British journal of clinical pharmacology
    38. TRENKWALDER P; GEISELER R; SCHLOSSBERGER M; LYDTIN H
      EFFICACY AND SAFETY OF ANTIHYPERTENSIVE T REATMENT WITH THE CALCIUM-ANTAGONIST FELODIPINE IN PATIENTS WITH HYPERTENSION AFTER ACUTE ISCHEMIC STROKE

      Nieren- und Hochdruckkrankheiten
    39. BENICHOU C; CASTLE W
      POINTS-OF-VIEW ON ADVERSE DRUG-REACTIONS TERMINOLOGY

      Therapie
    40. ERNST E; DESMET PAGM; SHAW D; MURRAY V
      TRADITIONAL REMEDIES AND THE TEST OF TIME

      European Journal of Clinical Pharmacology
    41. YERBY MS; ANNEGERS JF; BRUNI J; CRAGAN J; HOLMES L; JACOBS M; MITTENDORF R; BRANDENBURG N; CARROLL M; FIFE D; FORD L; KAMIN M; LUSCOMB F; NABULSI A; TENNIS P
      A NORTH-AMERICAN REGISTRY FOR EPILEPSY AND PREGNANCY, A UNIQUE PUBLICPRIVATE PARTNERSHIP OF HEALTH SURVEILLANCE/

      Epilepsia
    42. LOUPI E; BAUDARD S; DEBOIS H; PIGNATO F
      RISKS ASSOCIATED WITH VACCINATIONS

      Annales de medecine interne
    43. CZARNECKI A; MACIEJCZYK A
      PHARMACOVIGILANCE IN POLAND

      Pharmacoepidemiology and drug safety
    44. BELCHER G; HUBNER R; GEORGE M; ELMFELDT D; LUNDE H
      CANDESARTAN CILEXETIL - SAFETY AND TOLERABILITY IN HEALTHY-VOLUNTEERSAND PATIENTS WITH HYPERTENSION

      Journal of human hypertension
    45. OPIE LH
      CALCIUM-CHANNEL BLOCKERS FOR HYPERTENSION - DISSECTING THE EVIDENCE FOR ADVERSE-EFFECTS

      American journal of hypertension
    46. BERGQVIST PBF; WIKELL C; HJORTH S; APELQVIST G; BENGTSSON F
      EFFECT OF CITALOPRAM ON BRAIN-SEROTONIN RELEASE IN EXPERIMENTAL HEPATIC-ENCEPHALOPATHY - IMPLICATIONS FOR THYMOLEPTIC DRUG SAFETY IN LIVER INSUFFICIENCY

      Clinical neuropharmacology
    47. VANDENBERG E; LOHMANN N; FRIEDBURG D; RABE F
      REPORT OF GENERAL TEMPORARY ANTICOAGULATION IN THE TREATMENT OF ACUTECEREBRAL AND RETINAL ISCHEMIA

      VASA
    48. EDWARDS IR
      WHO CARES ABOUT PHARMACOVIGILANCE

      European Journal of Clinical Pharmacology
    49. ALTMEYER P; BERGMEYER V; WIENAND W
      PRACTICING DERMATOLOGISTS AND COMPOUNDING OF PRESCRIPTIONS - AN ANALYSIS OF 72615 PRESCRIPTIONS FROM NORDRHEIN-WESTFALEN, GERMANY

      Hautarzt
    50. MACKAY FJ; WILTON LV; PEARCE GL; FREEMANTLE SN; MANN RD
      SAFETY OF LONG-TERM LAMOTRIGINE IN EPILEPSY

      Epilepsia
    51. HAGEN NA; BABUL N
      COMPARATIVE CLINICAL EFFICACY AND SAFETY OF A NOVEL CONTROLLED-RELEASE OXYCODONE FORMULATION AND CONTROLLED-RELEASE HYDROMORPHONE IN THE TREATMENT OF CANCER PAIN

      Cancer
    52. ROSENTHAL J; BAHRMANN H; BENKERT K; BAUMGART P; BONNER G; KLEIN G; NEISS A; SCHNELLE K; FROHLICH ED
      ANALYSIS OF ADVERSE-EFFECTS AMONG PATIENTS WITH ESSENTIAL-HYPERTENSION RECEIVING AN ACE-INHIBITOR OR A BETA-BLOCKER

      Cardiology
    53. WILTON L; PEARCE G; EDET E; FREEMANTLE S; STEPHENS MDB; MANN RD
      THE SAFETY OF FINASTERIDE USED IN BENIGN PROSTATIC HYPERTROPHY - A NON-INTERVENTIONAL OBSERVATIONAL COHORT STUDY IN 14772 PATIENTS

      British Journal of Urology
    54. DIENER HC; HANTSON L
      CLINICAL-TRIALS FOR ACUTE STROKE THERAPY - PHASE-II VERSUS PHASE-III TRIALS

      Cerebrovascular diseases
    55. DHALIWAL HS; SLOAN P; ARKINSTALL WW; THIRLWELL MP; BABUL N; HARSANYI Z; DARKE AC
      RANDOMIZED EVALUATION OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CHRONIC CANCER PAIN

      Journal of pain and symptom management
    56. LINDHOLM LH
      ASSESSING THE SAFETY PROFILE OF A NEW ANTIHYPERTENSIVE AGENT

      Journal of hypertension
    57. SACILOTTO K; BAGHERI H; LAPEYREMESTRE M; MONTASTRUC JL; MONTASTRUC P
      ADVERSE DRUG-REACTIONS REPORTED BY NURSES AND COMPARISON WITH DOCTORSREPORTS

      Therapie
    58. DOVER SB; GRAHAM A; MOORE MR; MCCOLL KEL
      LOFEPRAMINE - A SAFE ANTI-DEPRESSANT IN ACUTE HEPATIC PORPHYRIA

      JOURNAL OF PSYCHOPHARMACOLOGY
    59. GOOREN LJG
      A 10-YEAR SAFETY STUDY OF THE ORAL ANDROGEN TESTOSTERONE UNDECANOATE

      Journal of andrology
    60. JENSEN PS; VITIELLO B; LEONARD H; LAUGHREN TP
      CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY - EXPANDING THE RESEARCH BASE

      Psychopharmacology bulletin
    61. GRAILLE V; LAPEYREMESTRE M; MONTASTRUC JL
      DRUG SAFETY - A SURVEY AMONG RESIDENTS OF A UNIVERSITY HOSPITAL

      Therapie
    62. SCHMIDT J; SCHMITT C; HOCKWIN O; PAULUS U; VONBERGMANN K
      OCULAR DRUG SAFETY AND HMG-COA-REDUCTASE INHIBITORS

      Ophthalmic research
    63. TRUMMEL CL
      REGULATION OF ORAL CHEMOTHERAPEUTIC PRODUCTS IN THE UNITED-STATES

      Journal of dental research
    64. HAYS H; HAGEN N; THIRLWELL M; DHALIWAL H; BABUL N; HARSANYI Z; DARKE AC
      COMPARATIVE CLINICAL EFFICACY AND SAFETY OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE HYDROMORPHONE FOR CHRONIC SEVERE CANCER PAIN

      Cancer
    65. BORLAK JT; HARSANY V; SCHNEBLE H; HAEGELE KD
      PNAT AND CYP2D6 GENE POLYMORPHISM IN EPILEPTIC PATIENTS

      Biochemical pharmacology
    66. BARBER N; WALLER P
      KILL OR CURE - ARE MODERN MEDICINES WORTH THE RISK

      Journal of the Royal Society of Medicine
    67. UEDA O; SUZUKI H; MATSUOKA A; SUGIYAMA O; ADACHI J
      AN APPLICATION OF IN-VITRO FERTILIZATION - EMBRYO CULTURE - EMBRYO-TRANSFER SYSTEM ON THE DRUG SAFETY EVALUATION - FERTILITY TEST OF MALE-MICE ADMINISTERED WITH THE ANTICANCER DRUG

      Jikken Dobutsu
    68. FELDMANN U
      EPIDEMIOLOGIC ASSESSMENT OF RISKS OF ADVERSE REACTIONS ASSOCIATED WITH INTERMITTENT EXPOSURE

      Biometrics
    69. WEIHRAUCH TR; BAUNACK AR
      VALUE OF ESOPHAGEAL PHARMACOMANOMETRY (EPM) FOR EVALUATION OF DRUG EFFECTS IN MAN

      Digestive diseases and sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 19:51:32